FORECASTING METHOD OF TREATMENT EFFICIENCY residual schizophrenia atypical antipsychotics

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 efficiency u043bu0435u0447u0435u043du0438u00a0 u0440u0435u0437u0438u0434u0443u0430u043bu044cu043du043eu0439 schizophrenia - i'm in u043du0435u0439u0440u043eu043bu0435u043fu0442u0438u043au0430u043cu0438 u0437u0430u043au043bu044eu0447u0430u0435u0442u0441u00a0 in identifying laboratory indicators of blood before le u0447u0435u043du0438u00a0 and baseline u0437u043du0430u0447u0435u043du0438u00a0u0445 apoptosis in peripheral blood u043du0435u0439u0442u0440u043eu0444u0438u043bu043eu0432 below 0.5%, the concentration of u043du0435u0439u0440u043eu0441u0442u0435u0440u043eu0438u0434u0430 u0434u0435u0433u0438u0434u0440u043eu044du043fu0438u0430u043du0434u0440u043eu0441u0442u0435u0440u043eu043du0430 (u0434u0433u044du0430) below 1.5 mkl / ml and u043eu0442u043du043eu0448 u0435u043du0438u0438 u0434u0433u044du0430 / cortisol below 0.3 predict low clinical efficacy in treatment of u0440u0435u0437u0438u0434u0443u0430u043bu044cu043du043eu0439 atypical neuroleptics for schizophrenia.